betahistine has been researched along with Conductive Hearing Loss in 1 studies
Betahistine: A histamine analog and H1 receptor agonist that serves as a vasodilator. It is used in MENIERE DISEASE and in vascular headaches but may exacerbate bronchial asthma and peptic ulcers.
betahistine : An aminoalkylpyridine that is pyridine substituted by a 2-(methylamino)ethyl group at position 2. It acts as a histamine agonist and a vasodilator, and is thought to improve the microcirculation of the labyrinth, resulting in reduced endolymphatic pressure. It is used (generally as the hydrochloride or mesylate salt) to reduce the symptoms of vertigo, tinnitus, and hearing loss associated with Meniere's disease.
Excerpt | Relevance | Reference |
---|---|---|
"In 12 patients there were recognized conductive hearing loss and they were excluded from therapy of betahistine." | 2.73 | [Therapy of tinnitus in children]. ( Drobik-Wasiewicz, K; Gryczyńska, D; Kotecki, M; Malicka, M, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gryczyńska, D | 1 |
Drobik-Wasiewicz, K | 1 |
Malicka, M | 1 |
Kotecki, M | 1 |
1 trial available for betahistine and Conductive Hearing Loss
Article | Year |
---|---|
[Therapy of tinnitus in children].
Topics: Adolescent; Audiometry; Betahistine; Child; Hearing Loss, Conductive; Humans; Tinnitus; Treatment Ou | 2007 |